These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6710555)

  • 61. Reducing the cost of phenytoin assays with in-house TDx reagents.
    Colbert DL; Turner GJ; Gooch JC
    Ann Clin Biochem; 1993 Nov; 30 ( Pt 6)():555-8. PubMed ID: 8304724
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Performance characteristics of four free phenytoin immunoassays.
    Roberts WL; Annesley TM; De BK; Moulton L; Juenke JM; Moyer TP
    Ther Drug Monit; 2001 Apr; 23(2):148-54. PubMed ID: 11294515
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rapid measurement of free anticonvulsant drugs by direct liquid chromatography of serum ultrafiltrates.
    Bock JL; Ben-Ezra J
    Clin Chem; 1985 Nov; 31(11):1884-7. PubMed ID: 3902289
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Detection of the antiepileptic drug phenytoin using a single free-standing piezoresistive microcantilever for therapeutic drug monitoring.
    Huang LS; Pheanpanitporn Y; Yen YK; Chang KF; Lin LY; Lai DM
    Biosens Bioelectron; 2014 Sep; 59():233-8. PubMed ID: 24732600
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of phenytoin and carbamazepine serum concentrations measured by high-performance liquid chromatography, the standard TDx assay, the enzyme multiplied immunoassay technique, and a new patient-side immunoassay cartridge system.
    Rambeck B; May TW; Jürgens MU; Blankenhorn V; Jürges U; Korn-Merker E; Sälke-Kellermann A
    Ther Drug Monit; 1994 Dec; 16(6):608-12. PubMed ID: 7878702
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The "ultra-free" ultrafiltration technique compared with equilibrium dialysis for determination of unbound thiopental concentrations in serum.
    Jung D; Mayersohn M; Perrier D
    Clin Chem; 1981 Jan; 27(1):166-8. PubMed ID: 7449102
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Digoxin-like immunoreactivity eliminated from serum by centrifugal ultrafiltration before fluorescence polarization immunoassay of digoxin.
    Christenson RH; Studenberg SD; Beck-Davis S; Sedor FA
    Clin Chem; 1987 Apr; 33(4):606-8. PubMed ID: 3549061
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Automated fluorescence polarization immunoassay for monitoring vancomycin.
    Schwenzer KS; Wang CH; Anhalt JP
    Ther Drug Monit; 1983; 5(3):341-5. PubMed ID: 6636261
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An automated real-time free phenytoin assay to replace the obsolete Abbott TDx method.
    Williams C; Jones R; Akl P; Blick K
    Lab Med; 2014; 45(1):48-51. PubMed ID: 24719985
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adaptation of total phenytoin reagent pack for measuring free phenytoin levels with the Abbott AxSYM immunoassay analyzer.
    Jarzabek JI; Kampa IS
    Ther Drug Monit; 1999 Feb; 21(1):134-6. PubMed ID: 10051067
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Microscale ultrafiltration technique for determining free drug in 50-microL serum samples.
    Wittfoht W; Duwe K; Kuhnz W; Nau H
    Clin Chem; 1984 Jun; 30(6):878-9. PubMed ID: 6426820
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Falsely increased immunoassay measurements of total and unbound phenytoin in critically ill uremic patients receiving fosphenytoin.
    Roberts WL; De BK; Coleman JP; Annesley TM
    Clin Chem; 1999 Jun; 45(6 Pt 1):829-37. PubMed ID: 10351992
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Discrepancy in serum phenytoin concentrations determined by two immunoassay methods in uremic patients.
    Reeves SE; Hanyok JJ; Amon SA; Godley PJ
    Am J Hosp Pharm; 1985 Feb; 42(2):359-61. PubMed ID: 3883766
    [No Abstract]   [Full Text] [Related]  

  • 74. Isolation of peptides from uremic plasma that inhibit phenytoin binding to normal plasma proteins.
    Kinniburgh DW; Boyd ND
    Clin Pharmacol Ther; 1981 Aug; 30(2):276-80. PubMed ID: 7249510
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Audit of a monitoring service for free phenytoin.
    Peterson GM; McLean S; von Witt RJ; Millingen KS
    Br J Clin Pharmacol; 1985 May; 19(5):693-7. PubMed ID: 3890911
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of renal transplantation on a major endogenous ligand retained in uremic serum.
    Mabuchi H; Nakahashi H; Hamajima T; Aikawa I; Oka T
    Am J Kidney Dis; 1989 Jan; 13(1):49-54. PubMed ID: 2643310
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Undetectable phenytoin serum levels by an automated particle-enhanced turbidimetric inhibition immunoassay in a patient with monoclonal IgM lambda.
    Brauchli YB; Scholer A; Schwietert M; Krähenbühl S
    Clin Chim Acta; 2008 Mar; 389(1-2):174-6. PubMed ID: 18082631
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A major inhibitor of phenytoin binding to serum protein in uremia.
    Mabuchi H; Nakahashi H
    Nephron; 1988; 48(4):310-4. PubMed ID: 3362278
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of the serum protein binding of maprotiline and phenytoin in uraemic patients on haemodialysis.
    Lynn K; Braithwaite R; Dawling S; Rosser R
    Eur J Clin Pharmacol; 1981 Jan; 19(1):73-7. PubMed ID: 7461027
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Monitoring phenytoin in salivary and plasma ultrafiltrates of pediatric patients.
    Bachmann K; Forney RB; Voeller K
    Ther Drug Monit; 1983; 5(3):325-9. PubMed ID: 6636260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.